Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyCellularComponent	nuclear ubiquitin ligase complex	BRCA2 SAMD11 ANAPC2 CBX8	1.07e-04	49	105	4	GO:0000152
Domain	S_TKc	CAMK2A SCYL3 OBSCN RPS6KC1 MYO3A LATS1 LATS2 BUB1 MAP3K19	1.92e-04	359	105	9	SM00220
Domain	SANT/Myb	RCOR2 RCOR3 TADA2A OSMR	2.07e-04	52	105	4	IPR001005
Domain	Pkinase	CAMK2A SCYL3 OBSCN RPS6KC1 MYO3A LATS1 LATS2 BUB1 MAP3K19	2.99e-04	381	105	9	PF00069
Domain	SANT_dom	RCOR2 RCOR3 TADA2A	4.09e-04	26	105	3	IPR017884
Domain	Prot_kinase_dom	CAMK2A SCYL3 OBSCN RPS6KC1 MYO3A LATS1 LATS2 BUB1 PAN3 MAP3K19	4.32e-04	489	105	10	IPR000719
Domain	PROTEIN_KINASE_DOM	CAMK2A SCYL3 OBSCN RPS6KC1 MYO3A LATS1 LATS2 BUB1 PAN3 MAP3K19	4.60e-04	493	105	10	PS50011
Domain	SANT	RCOR2 RCOR3 TADA2A	5.11e-04	28	105	3	PS51293
Domain	Ser/Thr_kinase_AS	CAMK2A OBSCN RPS6KC1 MYO3A LATS1 LATS2 BUB1 MAP3K19	9.18e-04	357	105	8	IPR008271
Domain	Kinase-like_dom	CAMK2A SCYL3 OBSCN RPS6KC1 MYO3A LATS1 LATS2 BUB1 PAN3 MAP3K19	9.53e-04	542	105	10	IPR011009
Domain	Myb_DNA-binding	RCOR2 RCOR3 TADA2A	9.91e-04	35	105	3	PF00249
Domain	PROTEIN_KINASE_ST	CAMK2A OBSCN RPS6KC1 MYO3A LATS1 LATS2 BUB1 MAP3K19	1.00e-03	362	105	8	PS00108
Domain	UBA	TNRC6C LATS1 LATS2	1.08e-03	36	105	3	PF00627
Domain	MYB_LIKE	RCOR2 RCOR3 TADA2A	1.26e-03	38	105	3	PS50090
Domain	-	TAF15 FUS	1.37e-03	10	105	2	4.10.1060.10
Domain	UBA	TNRC6C LATS1 LATS2	1.93e-03	44	105	3	IPR015940
Domain	UBA	TNRC6C LATS1 LATS2	2.34e-03	47	105	3	PS50030
Domain	ELM2	RCOR2 RCOR3	2.35e-03	13	105	2	PF01448
Domain	ELM2	RCOR2 RCOR3	2.35e-03	13	105	2	PS51156
Domain	ELM2_dom	RCOR2 RCOR3	2.35e-03	13	105	2	IPR000949
Domain	ELM2	RCOR2 RCOR3	2.35e-03	13	105	2	SM01189
Domain	SANT	RCOR2 RCOR3 TADA2A	2.79e-03	50	105	3	SM00717
Domain	PROTEIN_KINASE_ATP	CAMK2A OBSCN RPS6KC1 MYO3A LATS1 LATS2 BUB1 MAP3K19	4.37e-03	459	105	8	PS00107
Domain	UBA-like	TNRC6C LATS1 LATS2	5.61e-03	64	105	3	IPR009060
Pubmed	A FUS-LATS1/2 Axis Inhibits Hepatocellular Carcinoma Progression via Activating Hippo Pathway.	LATS1 LATS2 FUS	2.83e-08	3	107	3	30308519
Pubmed	The human cytoplasmic dynein interactome reveals novel activators of motility.	GGA2 ECD ANKRD26 SORBS1 TNRC6C LATS1 BRCA2 TAB1 FUS PAN3 AP4B1 FHIP1A ARHGAP21 CBX8	3.78e-07	853	107	14	28718761
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	CAMK2A ANKRD26 SORBS1 PABIR2 RUSC2 LATS1 TBC1D4 SAMD11 STARD9 SYNE2 TAB1 PAN3 OBI1 ARHGAP21	4.23e-07	861	107	14	36931259
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	CLSTN3 CAMK2A SORBS1 TNRC6C RUSC2 BAZ2A SETD5 STARD9 RIPOR1 ARHGAP21	5.53e-07	407	107	10	12693553
Pubmed	A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning.	GGA2 ECD SCYL3 RPSA TNRC6C PPP1R13L PABIR2 RUSC2 RIPOR1 TAB1 PAN3 AP4B1 OBI1 ARHGAP21 TGS1	7.00e-07	1038	107	15	26673895
Pubmed	LATS1/2 control TGFB-directed epithelial-to-mesenchymal transition in the murine dorsal cranial neuroepithelium through YAP regulation.	TGFB1 LATS1 LATS2	4.59e-06	11	107	3	36125128
Pubmed	Epidermal progenitors suppress GRHL3-mediated differentiation through intronic polyadenylation promoted by CPSF-HNRNPA3 collaboration.	TAF15 FUS GRHL3	4.59e-06	11	107	3	33469008
Pubmed	Proximity-dependent biotin identification (BioID) reveals a dynamic LSD1-CoREST interactome during embryonic stem cell differentiation.	RCOR2 GREB1L TBC1D4 BRCA2 BUB1 RCOR3 TADA2A OBI1 ARHGAP21	6.10e-06	418	107	9	34709266
Pubmed	Prediction of the coding sequences of unidentified human genes. XVI. The complete sequences of 150 new cDNA clones from brain which code for large proteins in vitro.	SORBS1 DNAH1 STARD9 ANAPC2 RCOR3 ARHGAP21	8.23e-06	153	107	6	10718198
Pubmed	In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.	MRPS31 ECD ANKRD26 RPS6KC1 LATS1 LATS2 SETD5 STARD9 SYNE2 TAF15 FUS ABCC2 KIAA2012 MTDH OBI1 ARHGAP21	8.67e-06	1442	107	16	35575683
Pubmed	Mutation analysis of large tumor suppressor genes LATS1 and LATS2 supports a tumor suppressor role in human cancer.	LATS1 LATS2	9.38e-06	2	107	2	25482410
Pubmed	Lats1/2-Mediated Alteration of Hippo Signaling Pathway Regulates the Fate of Bone Marrow-Derived Mesenchymal Stem Cells.	LATS1 LATS2	9.38e-06	2	107	2	30671453
Pubmed	A single copy of large tumor suppressor 1 or large tumor suppressor 2 is sufficient for normal hematopoiesis.	LATS1 LATS2	9.38e-06	2	107	2	32826458
Pubmed	AICAR Antiproliferative Properties Involve the AMPK-Independent Activation of the Tumor Suppressors LATS 1 and 2.	LATS1 LATS2	9.38e-06	2	107	2	29730476
Pubmed	TGF-β1 and BRCA2 expression are associated with clinical factors in breast cancer.	TGFB1 BRCA2	9.38e-06	2	107	2	21222048
Pubmed	N-terminal truncation of Lats1 causes abnormal cell growth control and chromosomal instability.	LATS1 LATS2	9.38e-06	2	107	2	23230145
Pubmed	AEG-1 participates in TGF-beta1-induced EMT through p38 MAPK activation.	TGFB1 MTDH	9.38e-06	2	107	2	23640911
Pubmed	LATS1 but not LATS2 represses autophagy by a kinase-independent scaffold function.	LATS1 LATS2	9.38e-06	2	107	2	31848340
Pubmed	Expression of LATS family proteins in ovarian tumors and its significance.	LATS1 LATS2	9.38e-06	2	107	2	25841306
Pubmed	Evidence for a tumor suppressor role for the large tumor suppressor genes LATS1 and LATS2 in human cancer.	LATS1 LATS2	9.38e-06	2	107	2	24026096
Pubmed	Association analysis between SNPs in LATS1 and LATS2 and non-cardia gastric cancer.	LATS1 LATS2	9.38e-06	2	107	2	32423384
Pubmed	Deletion of Lats1/2 in adult kidney epithelia leads to renal cell carcinoma.	LATS1 LATS2	9.38e-06	2	107	2	34060480
Pubmed	Promoter hypermethylation-mediated down-regulation of LATS1 and LATS2 in human astrocytoma.	LATS1 LATS2	9.38e-06	2	107	2	17049657
Pubmed	Lats1 and Lats2 are required for ovarian granulosa cell fate maintenance.	LATS1 LATS2	9.38e-06	2	107	2	31268774
Pubmed	Genomic structure of the human RBP56/hTAFII68 and FUS/TLS genes.	TAF15 FUS	9.38e-06	2	107	2	9795213
Pubmed	TGF-beta1 improves cardiac performance via up-regulation of laminin receptor 37/67 in adult ventricular cardiomyocytes.	RPSA TGFB1	9.38e-06	2	107	2	20556404
Pubmed	The Hippo pathway regulates human megakaryocytic differentiation.	LATS1 LATS2	9.38e-06	2	107	2	27786336
Pubmed	Cell type-dependent function of LATS1/2 in cancer cell growth.	LATS1 LATS2	9.38e-06	2	107	2	30531839
Pubmed	Down-regulation of LATS1 and LATS2 mRNA expression by promoter hypermethylation and its association with biologically aggressive phenotype in human breast cancers.	LATS1 LATS2	9.38e-06	2	107	2	15746036
Pubmed	Identification of LATS transcriptional targets in HeLa cells using whole human genome oligonucleotide microarray.	LATS1 LATS2	9.38e-06	2	107	2	19799973
Pubmed	Familial thrombocytopenia due to a complex structural variant resulting in a WAC-ANKRD26 fusion transcript.	ANKRD26 WAC	9.38e-06	2	107	2	33857290
Pubmed	LATS suppresses mTORC1 activity to directly coordinate Hippo and mTORC1 pathways in growth control.	LATS1 LATS2	9.38e-06	2	107	2	32015438
Pubmed	A novel immuno-competitive capture mass spectrometry strategy for protein-protein interaction profiling reveals that LATS kinases regulate HCV replication through NS5A phosphorylation.	LATS1 LATS2	9.38e-06	2	107	2	25044019
Pubmed	Deubiquitylase USP9X suppresses tumorigenesis by stabilizing large tumor suppressor kinase 2 (LATS2) in the Hippo pathway.	LATS1 LATS2 ANAPC2	1.01e-05	14	107	3	29183995
Pubmed	The proximal proteome of 17 SARS-CoV-2 proteins links to disrupted antiviral signaling and host translation.	MRPS31 GGA2 SCYL3 RPSA PABIR2 WAC TGFB1 LATS1 SYNE2 TAB1 FUS PAN3 MTDH	1.37e-05	1007	107	13	34597346
Pubmed	A human skeletal muscle interactome centered on proteins involved in muscular dystrophies: LGMD interactome.	MYOM3 OBSCN ANKRD26 SORBS1 TBC1D4 SYNE2 RCOR3 ARHGAP21 TGS1	2.40e-05	497	107	9	23414517
Pubmed	Selective interactions of hnRNP M isoforms with the TET proteins TAF15 and TLS/FUS.	TAF15 FUS	2.81e-05	3	107	2	24474660
Pubmed	The multifunctional FUS, EWS and TAF15 proto-oncoproteins show cell type-specific expression patterns and involvement in cell spreading and stress response.	TAF15 FUS	2.81e-05	3	107	2	18620564
Pubmed	mRNA and protein levels of FUS, EWSR1, and TAF15 are upregulated in liposarcoma.	TAF15 FUS	2.81e-05	3	107	2	21344536
Pubmed	Spatial organization of Hippo signaling at the plasma membrane mediated by the tumor suppressor Merlin/NF2.	LATS1 LATS2	2.81e-05	3	107	2	24012335
Pubmed	Aggregation of FET Proteins as a Pathological Change in Amyotrophic Lateral Sclerosis.	TAF15 FUS	2.81e-05	3	107	2	27311318
Pubmed	Impaired phosphorylation and mis-localization of Bub1 and BubR1 are responsible for the defective mitotic checkpoint function in Brca2-mutant thymic lymphomas.	BRCA2 BUB1	2.81e-05	3	107	2	14646599
Pubmed	Regulation of APC/C activity in oocytes by a Bub1-dependent spindle assembly checkpoint.	ANAPC2 BUB1	2.81e-05	3	107	2	19249208
Pubmed	O-GlcNAc glycosylation stoichiometry of the FET protein family: only EWS is glycosylated with a high stoichiometry.	TAF15 FUS	2.81e-05	3	107	2	27903134
Pubmed	Proteomic analysis of FUS interacting proteins provides insights into FUS function and its role in ALS.	TAF15 FUS	2.81e-05	3	107	2	27460707
Pubmed	Gene expression responses to FUS, EWS, and TAF15 reduction and stress granule sequestration analyses identifies FET-protein non-redundant functions.	TAF15 FUS	2.81e-05	3	107	2	23049996
Pubmed	LATS kinases and SLUG regulate the transition to advanced stage in aggressive oral cancer cells.	LATS1 LATS2	2.81e-05	3	107	2	35859006
Pubmed	A conserved N-terminal motif is required for complex formation between FUS, EWSR1, TAF15 and their oncogenic fusion proteins.	TAF15 FUS	2.81e-05	3	107	2	23975937
Pubmed	FET proteins TAF15 and EWS are selective markers that distinguish FTLD with FUS pathology from amyotrophic lateral sclerosis with FUS mutations.	TAF15 FUS	2.81e-05	3	107	2	21856723
Pubmed	Role of FET proteins in neurodegenerative disorders.	TAF15 FUS	2.81e-05	3	107	2	27415968
Pubmed	Negative regulation of YAP by LATS1 underscores evolutionary conservation of the Drosophila Hippo pathway.	LATS1 LATS2	2.81e-05	3	107	2	18413746
Pubmed	Characterization of a new brain-specific isoform of the EWS oncoprotein.	TAF15 FUS	2.81e-05	3	107	2	11422378
Pubmed	No association of TGFB1 L10P genotypes and breast cancer risk in BRCA1 and BRCA2 mutation carriers: a multi-center cohort study.	TGFB1 BRCA2	2.81e-05	3	107	2	18523885
Pubmed	Tumor suppressor LATS1 is a negative regulator of oncogene YAP.	LATS1 LATS2	2.81e-05	3	107	2	18158288
Pubmed	Integrative analysis of kinase networks in TRAIL-induced apoptosis provides a source of potential targets for combination therapy.	MRPS31 CAMK2A RPS6KC1 FAT1 LLGL1 ANAPC2 BUB1 FUS	3.51e-05	401	107	8	25852190
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	LAT2 MYOM3 OBSCN RPSA TNRC6C CTDNEP1 SBNO2 FAT1 LATS2 SETD5 TMEM132A RIPOR1 ARHGAP21	3.59e-05	1105	107	13	35748872
Pubmed	Identification of proteins interacting with protein arginine methyltransferase 8: the Ewing sarcoma (EWS) protein binds independent of its methylation state.	SYNE2 TAF15 FUS	4.79e-05	23	107	3	18320585
Pubmed	Protein-protein interactions between large proteins: two-hybrid screening using a functionally classified library composed of long cDNAs.	SORBS1 FOXJ3 DSCAML1 TBC1D4 TMEM132A	5.29e-05	130	107	5	12421765
Pubmed	Post-transcriptional regulation of FUS and EWS protein expression by miR-141 during neural differentiation.	TAF15 FUS	5.60e-05	4	107	2	28453628
Pubmed	Src Inhibits the Hippo Tumor Suppressor Pathway through Tyrosine Phosphorylation of Lats1.	LATS1 LATS2	5.60e-05	4	107	2	28754671
Pubmed	Potentiated Hsp104 variants suppress toxicity of diverse neurodegenerative disease-linked proteins.	TAF15 FUS	5.60e-05	4	107	2	25062688
Pubmed	Cytoplasmic ASPP1 inhibits apoptosis through the control of YAP.	LATS1 LATS2	5.60e-05	4	107	2	21041411
Pubmed	Hippo signalling maintains ER expression and ER+ breast cancer growth.	LATS1 LATS2	5.60e-05	4	107	2	33658690
Pubmed	Heat shock protein 90 inhibition depletes LATS1 and LATS2, two regulators of the mammalian hippo tumor suppressor pathway.	LATS1 LATS2	5.60e-05	4	107	2	20841485
Pubmed	Exome sequencing in seven families and gene-based association studies indicate genetic heterogeneity and suggest possible candidates for fibromuscular dysplasia.	OBSCN RNF213	5.60e-05	4	107	2	26147384
Pubmed	WWC1 and NF2 Prevent the Development of Intrahepatic Cholangiocarcinoma by Regulating YAP/TAZ Activity through LATS in Mice.	LATS1 LATS2	5.60e-05	4	107	2	32451369
Pubmed	The deubiquitinase USP44 promotes Treg function during inflammation by preventing FOXP3 degradation.	TGFB1 USP44	5.60e-05	4	107	2	32644293
Pubmed	Phosphorylation of CHO1 by Lats1/2 regulates the centrosomal activation of LIMK1 during cytokinesis.	LATS1 LATS2	5.60e-05	4	107	2	25786116
Pubmed	Hippo signaling instructs ectopic but not normal organ growth.	LATS1 LATS2	5.60e-05	4	107	2	36395225
Pubmed	Lats2/Kpm is required for embryonic development, proliferation control and genomic integrity.	LATS1 LATS2	5.60e-05	4	107	2	15343267
Pubmed	Inactivation of the Hippo tumor suppressor pathway promotes melanoma.	LATS1 LATS2	5.60e-05	4	107	2	35768444
Pubmed	KIBRA regulates Hippo signaling activity via interactions with large tumor suppressor kinases.	LATS1 LATS2	5.60e-05	4	107	2	21233212
Pubmed	The tumor suppressor Lats2 is pivotal in Aurora A and Aurora B signaling during mitosis.	LATS1 LATS2	5.60e-05	4	107	2	21822051
Pubmed	The neurodegenerative diseases ALS and SMA are linked at the molecular level via the ASC-1 complex.	TAF15 FUS	5.60e-05	4	107	2	30398641
Pubmed	RASSF1A-Mediated Suppression of Estrogen Receptor Alpha (ERα)-Driven Breast Cancer Cell Growth Depends on the Hippo-Kinases LATS1 and 2.	LATS1 LATS2	5.60e-05	4	107	2	34831091
Pubmed	Binding of Kif23-iso1/CHO1 to 14-3-3 is regulated by sequential phosphorylations at two LATS kinase consensus sites.	LATS1 LATS2	5.60e-05	4	107	2	25658096
Pubmed	The transcriptional repressor ZFM1 interacts with and modulates the ability of EWS to activate transcription.	TAF15 FUS	5.60e-05	4	107	2	9660765
Pubmed	The TRIM9/TRIM67 neuronal interactome reveals novel activators of morphogenesis.	GGA2 SORBS1 TNRC6C PPP1R13L LATS1 TAB1	6.04e-05	218	107	6	33378226
Pubmed	The Crumbs complex couples cell density sensing to Hippo-dependent control of the TGF-β-SMAD pathway.	TGFB1 LATS1 LATS2	6.20e-05	25	107	3	21145499
Pubmed	Novel interactors and a role for supervillin in early cytokinesis.	STARD9 BUB1 PAN3	8.77e-05	28	107	3	20309963
Pubmed	Competitive binding of E3 ligases TRIM26 and WWP2 controls SOX2 in glioblastoma.	ANKRD26 RPSA PPP1R13L TGFB1 PWP1 USP44 PREP TAF15 ABCC2 ARHGAP21	9.00e-05	732	107	10	34732716
Pubmed	Phosphorylation of angiomotin by Lats1/2 kinases inhibits F-actin binding, cell migration, and angiogenesis.	LATS1 LATS2	9.32e-05	5	107	2	24106267
Pubmed	The Hippo kinases LATS1 and 2 control human breast cell fate via crosstalk with ERα.	LATS1 LATS2	9.32e-05	5	107	2	28068668
Pubmed	Angiomotin binding-induced activation of Merlin/NF2 in the Hippo pathway.	LATS1 LATS2	9.32e-05	5	107	2	26045165
Pubmed	The Hippo pathway links adipocyte plasticity to adipose tissue fibrosis.	LATS1 LATS2	9.32e-05	5	107	2	36229481
Pubmed	Control of skeletal morphogenesis by the Hippo-YAP/TAZ pathway.	LATS1 LATS2	9.32e-05	5	107	2	32994166
Pubmed	Differential NDR/LATS interactions with the human MOB family reveal a negative role for human MOB2 in the regulation of human NDR kinases.	LATS1 LATS2	9.32e-05	5	107	2	20624913
Pubmed	Myofibroblast YAP/TAZ activation is a key step in organ fibrogenesis.	LATS1 LATS2	9.32e-05	5	107	2	35191398
Pubmed	Homeostatic control of Hippo signaling activity revealed by an endogenous activating mutation in YAP.	LATS1 LATS2	9.32e-05	5	107	2	26109051
Pubmed	RASSF1A-LATS1 signalling stabilizes replication forks by restricting CDK2-mediated phosphorylation of BRCA2.	LATS1 BRCA2	9.32e-05	5	107	2	25218637
Pubmed	Programming of Schwann Cells by Lats1/2-TAZ/YAP Signaling Drives Malignant Peripheral Nerve Sheath Tumorigenesis.	LATS1 LATS2	9.32e-05	5	107	2	29438698
Pubmed	The Hippo Pathway Blocks Mammalian Retinal Müller Glial Cell Reprogramming.	LATS1 LATS2	9.32e-05	5	107	2	31067451
Pubmed	Distinct and shared functions of ALS-associated proteins TDP-43, FUS and TAF15 revealed by multisystem analyses.	TAF15 FUS	9.32e-05	5	107	2	27378374
Pubmed	Single-Cell Transcriptomics in Medulloblastoma Reveals Tumor-Initiating Progenitors and Oncogenic Cascades during Tumorigenesis and Relapse.	LATS1 LATS2	9.32e-05	5	107	2	31474569
Pubmed	Mst2 and Lats kinases regulate apoptotic function of Yes kinase-associated protein (YAP).	LATS1 LATS2	9.32e-05	5	107	2	18640976
Pubmed	Distinct fibroblast subsets regulate lacteal integrity through YAP/TAZ-induced VEGF-C in intestinal villi.	LATS1 LATS2	9.32e-05	5	107	2	32796823
Pubmed	YAP/TAZ-CDC42 signaling regulates vascular tip cell migration.	LATS1 LATS2	9.32e-05	5	107	2	28973878
Pubmed	YAP/TAZ regulates sprouting angiogenesis and vascular barrier maturation.	LATS1 LATS2	9.32e-05	5	107	2	28805663
Pubmed	Induced ncRNAs allosterically modify RNA-binding proteins in cis to inhibit transcription.	TAF15 FUS	1.40e-04	6	107	2	18509338
Pubmed	Single-cell transcriptomes of the regenerating intestine reveal a revival stem cell.	LATS1 LATS2	1.40e-04	6	107	2	31019301
Interaction	NINL interactions	GGA2 CAMK2A ANKRD26 TNRC6C RGS2 DNAH1 LATS1 TBC1D4 LATS2 BRCA2 ANAPC2 RCOR3 FUS PAN3 ARHGAP21	1.74e-08	458	106	15	int:NINL
Cytoband	10p12.1	ANKRD26 WAC ARHGAP21	5.81e-05	32	107	3	10p12.1
Cytoband	Ensembl 112 genes in cytogenetic band chr10p12	ANKRD26 WAC MYO3A ARHGAP21	3.35e-04	140	107	4	chr10p12
GeneFamily	GATA zinc finger domain containing\|Myb/SANT domain containing	RCOR2 RCOR3 TADA2A	9.14e-04	53	65	3	532
GeneFamily	Dyneins, axonemal	DNAH1 DNAI2	1.67e-03	17	65	2	536
GeneFamily	Cadherin related	CLSTN3 FAT1	1.67e-03	17	65	2	24
GeneFamily	Zinc fingers RANBP2-type \|RNA binding motif containing	TAF15 FUS	2.56e-03	21	65	2	89
GeneFamily	Fibronectin type III domain containing	MYOM3 OBSCN DSCAML1 OSMR	2.63e-03	160	65	4	555
Coexpression	GSE20152_HTNFA_OVERXPRESS_ANKLE_VS_CTRL_SPHK1_KO_ANKLE_UP	ELP5 LAT2 CAMK2A APOBR RUSC2 TGFB1 OSMR METTL22	1.47e-06	196	107	8	M7687
Coexpression	BUSSLINGER_GASTRIC_IMMUNE_CELLS	CLSTN3 GGA2 RNF213 DENND1C TNRC6C FOXJ3 APOBR FAM13B RGS2 SBNO2 WAC TGFB1 LATS1 TBC1D4 SETD5 FUS AP4B1 MTDH NSMAF	8.96e-06	1492	107	19	M40023
ToppCell	PND07-28-samps-Epithelial-Epithelial-non_alveolar-Ciliated_cell_of_lung_parenchyma\|PND07-28-samps / Age Group, Lineage, Cell class and subclass	ERICH3 DNAH1 DNAI2 VWA3B PROB1 KIAA2012	4.01e-06	174	107	6	f41d05a3703d7092bd3c4a97c15ae13069aaa4ad
ToppCell	PND07-28-samps-Epithelial-Epithelial-non_alveolar\|PND07-28-samps / Age Group, Lineage, Cell class and subclass	ERICH3 DNAH1 DNAI2 VWA3B PROB1 KIAA2012	4.15e-06	175	107	6	c01a15b2084da4a18f8ff3623f44eb9dfe499f10
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HECW1 OBSCN DSCAML1 DNAH1 FAT1 UNC13C	5.53e-06	184	107	6	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HECW1 OBSCN DSCAML1 DNAH1 FAT1 UNC13C	5.53e-06	184	107	6	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HECW1 OBSCN DSCAML1 DNAH1 FAT1 UNC13C	5.53e-06	184	107	6	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	Adult-Epithelial-ciliated_cell-D175\|Adult / Lineage, Cell type, age group and donor	ERICH3 DSCAML1 DNAI2 VWA3B KIAA2012 MAP3K19	5.71e-06	185	107	6	30f4980dee6cd5959655f8d74049f3bfb5312611
ToppCell	IPF-Epithelial-Ciliated\|Epithelial / Disease state, Lineage and Cell class	MRPS31 ERICH3 DNAI2 VWA3B KIAA2012 MAP3K19	7.27e-06	193	107	6	ad58f5080e0ba65c845056ea6b79037b636e9c64
ToppCell	3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	MRPS31 ERICH3 DNAI2 VWA3B KIAA2012 MAP3K19	7.49e-06	194	107	6	a46238514bca920c3e3713d23c18ba24a09e2a29
ToppCell	COVID-19-Heart-CM_1\|Heart / Disease (COVID-19 only), tissue and cell type	MYOM3 OBSCN SORBS1 GREB1L TBC1D4 FHIP1A	7.71e-06	195	107	6	f1ef50331eda8f1239dba6ea970df4eaccf032f1
ToppCell	3'-Broncho-tracheal-Epithelial-Airway_ciliated\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	MRPS31 ERICH3 DNAI2 VWA3B KIAA2012 MAP3K19	7.71e-06	195	107	6	0e763f36786515698b593e5c93f6a56619c1242d
ToppCell	3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	MRPS31 ERICH3 DNAI2 VWA3B KIAA2012 MAP3K19	7.71e-06	195	107	6	581b04220587e1d5198b1abd6965965ace7803e7
ToppCell	3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	MRPS31 ERICH3 DNAI2 VWA3B KIAA2012 MAP3K19	7.71e-06	195	107	6	93b1559382a12cfb158aa5fac7386e38b4f87989
ToppCell	normal_Lymph_Node-Myeloid_cells-CD1c+_DCs\|Myeloid_cells / Location, Cell class and cell subclass	LAT2 RPSA CTDNEP1 RGS2 TGFB1 MIDN	8.17e-06	197	107	6	2b3cd318c988364adcba4441444045914d58fe46
ToppCell	Tracheal-NucSeq-Epithelial-Epi_airway_ciliated-Deuterosomal\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	ERICH3 MYO3A BUB1 DNAI2 MTFR2 MAP3K19	8.41e-06	198	107	6	f31790442ef142f1c0c49bf3daf2d0efb193d2c9
ToppCell	Tracheal-10x5prime-Epithelial-Epi_airway_ciliated\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	ERICH3 DNAH1 DNAI2 VWA3B KIAA2012 MAP3K19	8.91e-06	200	107	6	31d75c26055177d656df1fbb10b764cebd61e122
ToppCell	LPS_IL1RA-Epithelial_airway-airway_epithelial-Ciliated\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	ERICH3 DNAH1 NRSN2 DNAI2 VWA3B MAP3K19	8.91e-06	200	107	6	4992dbf0514d674017315dbd20d91dfec0c608e9
ToppCell	Tracheal-10x5prime-Epithelial-Epi_airway_ciliated-Ciliated\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	ERICH3 DNAH1 DNAI2 VWA3B KIAA2012 MAP3K19	8.91e-06	200	107	6	e1dce91c6c531bb212002a14705e496d77ad3490
ToppCell	facs-Pancreas-Endocrine-3m-Epithelial-pancreatic_acinar_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DSCAML1 F10 TGFB1 MTFR2	2.90e-05	73	107	4	3ac392ac46ad577c7d2c2b5e6a0a96ceb613097b
ToppCell	facs-Pancreas-Endocrine-3m-Epithelial-pancreatic_acinar_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DSCAML1 F10 TGFB1 MTFR2	2.90e-05	73	107	4	1bd6ff9659efc43b0a596da50e325bde2f0ba8f7
ToppCell	COVID-19-Epithelial_cells-Airway_mucous\|COVID-19 / group, cell type (main and fine annotations)	ERICH3 DNAI2 VWA3B KIAA2012 FHIP1A	3.22e-05	151	107	5	8216462e723fec2797387929dde095370947e10a
ToppCell	PND01-03-samps-Epithelial-Epithelial-non_alveolar\|PND01-03-samps / Age Group, Lineage, Cell class and subclass	ERICH3 DNAI2 VWA3B PROB1 KIAA2012	3.42e-05	153	107	5	fc0d2d50aa3b6b2772bbf3626c9df5c5e8d7d11e
ToppCell	PND01-03-samps-Epithelial-Epithelial-non_alveolar-Ciliated_cell_of_lung_parenchyma\|PND01-03-samps / Age Group, Lineage, Cell class and subclass	ERICH3 DNAI2 VWA3B PROB1 KIAA2012	3.42e-05	153	107	5	2482247d9c39c7b99bb45fb9153442f64fd6012f
ToppCell	PND07-Immune-Immune_Myeloid-Granulocytic\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	LAT2 APOBR TBC1D4 KIAA2012 HDC	3.53e-05	154	107	5	f92d83c5f8b532fe5624f1cd352632f543d96ea9
ToppCell	E16.5-Immune-Immune_Myeloid-Granulocytic\|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	LAT2 TBC1D4 ABCC2 KIAA2012 HDC	3.64e-05	155	107	5	c648512305166d2a2f0e284c127bc802af908071
ToppCell	VE-Treg-naive_CD4\|VE / Condition, Cell_class and T cell subcluster	ANKRD26 ZC3H11B PNMA5 LLGL1 SYNE2	3.76e-05	156	107	5	6501baf73616e702946de9fb13d267e30a68888b
ToppCell	facs-Diaphragm-Limb_Muscle-24m-Lymphocytic-T_cell\|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RGS2 PNMA5 TBC1D4 ABCC2 MAPK8IP2	3.76e-05	156	107	5	0bd32876413f3308f838f266e8c39ea0937ce5b9
ToppCell	facs-Marrow-T_cells-18m-Myeloid-basophil\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TBC1D4 SAMD11 ABCC2 KIAA2012 HDC	5.05e-05	166	107	5	c22b0f3bf990d94b615a3aacee5de548da2db628
ToppCell	facs-Marrow-T_cells-18m-Myeloid-basophil\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TBC1D4 SAMD11 ABCC2 KIAA2012 HDC	5.05e-05	166	107	5	0975fc165bcc7e85f053d9d0244fffe407c23571
ToppCell	PND10-Epithelial-Epithelial_Airway-Neurosecretory-Secretory-Secretory_G2M\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	SYTL5 BUB1 PROB1 UNC13C FHIP1A	5.20e-05	167	107	5	a90f905ef38437752e2b0b71bd0322a184de1861
ToppCell	5'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	DNAH1 RNF103 DNAI2 VWA3B MAP3K19	5.50e-05	169	107	5	fba841664939c771881ba97f14ef1df6635c04ff
ToppCell	wk_08-11-Epithelial-Proximal_epithelial-Deuterosomal\|wk_08-11 / Celltypes from embryonic and fetal-stage human lung	ERICH3 DNAI2 VWA3B KIAA2012 MAP3K19	5.98e-05	172	107	5	08ad76412c9cc3504141797b44b88478ced87476
ToppCell	droplet-Lung-LUNG-30m-Myeloid-Basophil\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LAT2 PDK3 RGS2 TBC1D4 HDC	6.14e-05	173	107	5	4f849d236ee358ad30ac977745ac43c8e9778e94
ToppCell	3'-Distal_airway-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ERICH3 MYO3A DNAI2 VWA3B MAP3K19	6.14e-05	173	107	5	c3762655caa79ac4879876f470d32578a3c93b01
ToppCell	droplet-Lung-LUNG-30m-Myeloid-basophil\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LAT2 PDK3 RGS2 TBC1D4 HDC	6.14e-05	173	107	5	39c3b8313354c4c60764597507a2505dcfa4e8c7
ToppCell	droplet-Lung-1m-Hematologic-myeloid-Basophil/Mast_cell\|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	LAT2 RGS2 TBC1D4 KIAA2012 HDC	6.14e-05	173	107	5	117163c5cd2b7aaa1c0682c8ac44b4249df4d2f8
ToppCell	droplet-Lung-immune-endo-depleted-3m-Myeloid-basophil\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LAT2 TBC1D4 SAMD11 PAN3 HDC	6.14e-05	173	107	5	3612772632ddf11eb48579cae9a8ccab6b3f1f52
ToppCell	droplet-Lung-immune-endo-depleted-3m-Myeloid-Basophil\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LAT2 TBC1D4 SAMD11 PAN3 HDC	6.14e-05	173	107	5	4dc261ebcdb9bdcfca1451da1bd254f0dc5de203
ToppCell	E16.5-Immune-Immune_Myeloid-Granulocytic-Basophil\|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	LAT2 TBC1D4 ABCC2 KIAA2012 HDC	6.14e-05	173	107	5	2cba41c3d9d3076f703115d19729073a3ac3feb6
ToppCell	E16.5-Immune-Immune_Myeloid-Granulocytic-Basophil-Basophil_mature\|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	LAT2 TBC1D4 ABCC2 KIAA2012 HDC	6.14e-05	173	107	5	11d69a4ab4a87b8820cd3bd204de8c4124450a90
ToppCell	droplet-Lung-1m-Hematologic-myeloid-Basophil/Mast_cell-basophil_l26\|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	LAT2 RGS2 TBC1D4 KIAA2012 HDC	6.14e-05	173	107	5	01df9baeedf30e3a4891738554cdd300394dbb96
ToppCell	droplet-Lung-30m-Hematologic-myeloid-Basophil/Mast_cell-basophil_l26\|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	LAT2 PDK3 TBC1D4 KIAA2012 HDC	6.31e-05	174	107	5	009e88a6c79689a5d88b0af50aa89aa03b33f800
ToppCell	Fetal_29-31_weeks-Epithelial-ciliated_cell-D062\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	ERICH3 DNAI2 VWA3B KIAA2012 MAP3K19	7.03e-05	178	107	5	de5d50d7ca9ee9eb62f50c88a0c6d47f0694b2e6
ToppCell	5'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Multiciliated_(nasal)-Multiciliated_(nasal)_L.0.3.1.1\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ERICH3 DNAI2 VWA3B KIAA2012 MAP3K19	7.41e-05	180	107	5	1f1af4474f3f0ac3c0d6b1a6c875c354d36d8eec
ToppCell	3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	DNAH1 DNAI2 VWA3B KIAA2012 MAP3K19	7.41e-05	180	107	5	92fb01b91261b3103454924cde56add337b41844
ToppCell	wk_08-11-Epithelial-Proximal_epithelial-Ciliated\|wk_08-11 / Celltypes from embryonic and fetal-stage human lung	ERICH3 DNAI2 VWA3B KIAA2012 MAP3K19	7.61e-05	181	107	5	8eed9d46d924b16f6dd1a025ff612244b02b4391
ToppCell	Fetal_29-31_weeks-Epithelial-ciliated_cell-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	ERICH3 DNAI2 VWA3B KIAA2012 MAP3K19	7.61e-05	181	107	5	dfce05bd472f67e6e2bb60ebd6fd34f0a9aeeca6
ToppCell	Control-Epithelial_cells-Airway_ciliated\|Control / group, cell type (main and fine annotations)	ERICH3 DNAI2 VWA3B KIAA2012 MAP3K19	7.81e-05	182	107	5	fb725d10d9ed25dfc6d5bb69cfef78513f7d3e8f
ToppCell	CV-Severe-3\|CV / Virus stimulation, Condition and Cluster	TGFB1 NRSN2 BRCA2 BUB1 MTFR2	8.22e-05	184	107	5	1c9bda00bb6efd98f68781ca06655bf6c4282f27
ToppCell	LV-15._Ventricular_Cardiomyocyte_III\|LV / Chamber and Cluster_Paper	MYOM3 OBSCN SORBS1 GREB1L TBC1D4	8.22e-05	184	107	5	ab7a1620c14a9d9b6be1b47c559931e345e9eef8
ToppCell	Children_(3_yrs)-Epithelial-ciliated_cell-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	ERICH3 DNAI2 VWA3B KIAA2012 MAP3K19	8.22e-05	184	107	5	5daff849625f2f41d56615569c0ed59cd733b34c
ToppCell	Ciliated_cells-B-IPF_02\|World / lung cells shred on cell class, cell subclass, sample id	ERICH3 DNAI2 VWA3B KIAA2012 MAP3K19	8.43e-05	185	107	5	4fc7113d3dadc716ec5a8e62b58543cc00ce5b16
ToppCell	Ciliated_cells-B-Myositis-ILD_01\|World / lung cells shred on cell class, cell subclass, sample id	ERICH3 DNAI2 VWA3B KIAA2012 MAP3K19	8.43e-05	185	107	5	f012c243343e1d1956db19b34d062e9b13de2b2a
ToppCell	LV-15._Ventricular_Cardiomyocyte_III\|World / Chamber and Cluster_Paper	MYOM3 OBSCN SORBS1 GREB1L TBC1D4	8.43e-05	185	107	5	6baccb26f999145e51b91d94315bf8d4655bef31
ToppCell	Fetal_29-31_weeks-Epithelial-ciliated_cell-D150\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	ERICH3 DNAI2 VWA3B KIAA2012 MAP3K19	8.43e-05	185	107	5	3e39a3cb534dfe2301930f3e2f7e8cefb522c158
ToppCell	COVID-19-Epithelial_cells-Airway_ciliated\|COVID-19 / group, cell type (main and fine annotations)	ERICH3 DNAI2 VWA3B KIAA2012 MAP3K19	8.43e-05	185	107	5	18a40f0a338aa398d81384b5159fb80ce8a2020c
ToppCell	facs-Lung-EPCAM-3m-Epithelial-Ciliated_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ERICH3 DNAH1 DNAI2 KIAA2012 MAP3K19	8.87e-05	187	107	5	04dba2ed09ee4180830bdf0191921696697ea234
ToppCell	Ciliated_cells-B-IPF_03\|World / lung cells shred on cell class, cell subclass, sample id	ERICH3 DNAI2 VWA3B KIAA2012 MAP3K19	8.87e-05	187	107	5	6fa38dbccca36bc7a4fef46de74c6688f599f421
ToppCell	CV-Severe-3\|Severe / Virus stimulation, Condition and Cluster	TGFB1 NRSN2 BRCA2 BUB1 MTFR2	8.87e-05	187	107	5	68cb43a73945f5e252530da25613f6b3f484b4d5
ToppCell	Fetal_29-31_weeks-Epithelial-ciliated_cell\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	ERICH3 DNAI2 VWA3B KIAA2012 MAP3K19	8.87e-05	187	107	5	9e10ed56090d82589bc457788282f664b70ace4b
ToppCell	facs-Lung-EPCAM-3m-Epithelial-ciliated_columnar_cell_of_tracheobronchial_tree\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ERICH3 DNAH1 DNAI2 KIAA2012 MAP3K19	8.87e-05	187	107	5	805dafe22f835ece4dd091d8030d0a63b52a48dd
ToppCell	COVID-19-kidney-Mito-rich_PCT\|kidney / Disease (COVID-19 only), tissue and cell type	HECW1 MYOM3 DSCAML1 SYNE2 ABCC2	8.87e-05	187	107	5	738ec2611b4be6a08eedad16b57fba84e1f11fef
ToppCell	Epithelial-ciliated_cell\|World / Lineage, Cell type, age group and donor	ERICH3 DNAI2 VWA3B KIAA2012 MAP3K19	9.09e-05	188	107	5	61a459f3fe57e5728efc72637ff2edc2d343492b
ToppCell	LV-04._Ventricular_Cardiomyocyte_I\|World / Chamber and Cluster_Paper	MYOM3 OBSCN PPP1R13L TBC1D4 FHIP1A	9.09e-05	188	107	5	0758b474457efa36488e0195f7357100f4b6a090
ToppCell	Adult-Epithelial-ciliated_cell-D231\|Adult / Lineage, Cell type, age group and donor	ERICH3 DNAI2 VWA3B KIAA2012 MAP3K19	9.09e-05	188	107	5	34b11f72ca73153d02edcd09b38983ad1a504659
ToppCell	Children_(3_yrs)-Epithelial-ciliated_cell\|Children_(3_yrs) / Lineage, Cell type, age group and donor	ERICH3 DNAI2 VWA3B KIAA2012 MAP3K19	9.09e-05	188	107	5	2b6dfc88be9ded7b88da9fe78a9cd9f9b3af8af3
ToppCell	COVID-19-lung-Ciliated\|COVID-19 / Disease (COVID-19 only), tissue and cell type	ERICH3 DNAI2 VWA3B KIAA2012 MAP3K19	9.32e-05	189	107	5	a2da5debd10f27b1280b40141ef0bfef007cc72c
ToppCell	Children_(3_yrs)-Epithelial-ciliated_cell-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	ERICH3 DNAI2 VWA3B KIAA2012 MAP3K19	9.32e-05	189	107	5	68a3cf7763d6f9b95d6d6524eff7a16042703f1d
ToppCell	Transplant_Alveoli_and_parenchyma-Epithelial-Ciliated_1\|Transplant_Alveoli_and_parenchyma / Tissue, Lineage and Cell class of Lung Cells from 10X	ERICH3 DNAI2 VWA3B KIAA2012 MAP3K19	9.32e-05	189	107	5	dc440015949a768188c67661b6be63b1ead1a0f0
ToppCell	cellseq2-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal\|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	ERICH3 DNAI2 VWA3B KIAA2012 MAP3K19	9.32e-05	189	107	5	a3cd4c2da4feb9bdcd8957f3e344d095da1367b8
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	HECW1 MYOM3 MYO3A FAT1 SYNE2	9.32e-05	189	107	5	28b502611829e4a24caff2562545c7db97686099
ToppCell	Adult-Epithelial-ciliated_cell\|Adult / Lineage, Cell type, age group and donor	ERICH3 DNAI2 VWA3B KIAA2012 MAP3K19	9.32e-05	189	107	5	b679920f0993e917dd86da082113bfbd85ea1ca5
ToppCell	COVID-19-kidney-PCT-S2\|kidney / Disease (COVID-19 only), tissue and cell type	MYOM3 DSCAML1 FAT1 SYNE2 ABCC2	9.32e-05	189	107	5	0be5c669b6b308bd98ddb70c84877c62a6244bbd
ToppCell	COVID-19-lung-Ciliated\|lung / Disease (COVID-19 only), tissue and cell type	ERICH3 DNAI2 VWA3B KIAA2012 MAP3K19	9.32e-05	189	107	5	27329c4661aebabd19fac7fe5dca263fe99d76f3
ToppCell	COPD-Epithelial-Ciliated\|Epithelial / Disease state, Lineage and Cell class	MRPS31 ERICH3 DNAI2 VWA3B KIAA2012	9.32e-05	189	107	5	3e77883db34722b9ce0a03ea74caefc92dc7feff
ToppCell	cellseq2-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated\|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	ERICH3 DNAI2 VWA3B KIAA2012 MAP3K19	9.32e-05	189	107	5	93b1026bb1ba759e5704561c9a5de14a30c08894
ToppCell	Nasal_Brush-Epithelial-Ciliated_2\|Nasal_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X	ERICH3 DNAI2 VWA3B KIAA2012 MAP3K19	9.56e-05	190	107	5	9ce7df056bfb24d70db4c3c4a2c57d89115de877
ToppCell	Nasal_Brush-Epithelial-Ciliated_2\|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X	ERICH3 DNAI2 VWA3B KIAA2012 MAP3K19	9.56e-05	190	107	5	833481ace2800354712e2ce709d5cdfd0aed3d42
ToppCell	Transplant_Alveoli_and_parenchyma-Epithelial-Ciliated_1\|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X	ERICH3 DNAI2 VWA3B KIAA2012 MAP3K19	9.56e-05	190	107	5	a90a38fccdbf75a286b4d258fc54920c02b282f7
ToppCell	cellseq2-Epithelial-Epithelial_Airway\|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	ERICH3 DNAI2 VWA3B KIAA2012 MAP3K19	9.56e-05	190	107	5	17829f4de31b3d9e4d71ba4817d18842aa699773
ToppCell	LV-06._Ventricular_Cardiomyocyte_II\|LV / Chamber and Cluster_Paper	MYOM3 OBSCN SORBS1 GREB1L TBC1D4	9.80e-05	191	107	5	25f3eb34f4e70761e81e84c8a5829f216108cbc6
ToppCell	nucseq-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	ERICH3 DNAI2 VWA3B KIAA2012 MAP3K19	9.80e-05	191	107	5	e417bf491f8b8d7838a61f7f4f6b1740ba97aa3f
ToppCell	nucseq-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	ERICH3 DNAI2 VWA3B KIAA2012 MAP3K19	9.80e-05	191	107	5	9d31c8424d35bdc0c27188b68bfd0f731af3600b
ToppCell	wk_15-18-Epithelial-Proximal_epithelial-MUC16+_ciliated\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	ERICH3 DNAI2 VWA3B KIAA2012 MAP3K19	9.80e-05	191	107	5	e81cd65dbf0ef1c2ab7088f73ce605d456dd3a7a
ToppCell	nucseq-Epithelial-Epithelial_Airway\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	ERICH3 DNAI2 VWA3B KIAA2012 MAP3K19	9.80e-05	191	107	5	1c528f72c9ef3ef3a850b05e4a9715190832270c
ToppCell	normal_Lung-Epithelial_cells-Ciliated\|normal_Lung / Location, Cell class and cell subclass	MRPS31 ERICH3 DNAI2 VWA3B MAP3K19	1.00e-04	192	107	5	097a13121820ab4e5cd2365600efccf5ea4ce8c3
ToppCell	Bronchial_Biopsy-Epithelial-Ciliated_1\|Bronchial_Biopsy / Tissue, Lineage and Cell class of Lung Cells from 10X	ERICH3 DNAI2 VWA3B KIAA2012 MAP3K19	1.00e-04	192	107	5	be592e661367affced9ebe80849b466e6adb3a34
ToppCell	LV-04._Ventricular_Cardiomyocyte_I\|LV / Chamber and Cluster_Paper	MYOM3 OBSCN GREB1L TBC1D4 FHIP1A	1.00e-04	192	107	5	ad19e2c1d36a0566c9b12ced10db78f4781c8ea6
ToppCell	Ciliated-cil-3\|World / Class top	ERICH3 DNAH1 DNAI2 KIAA2012 HDC	1.00e-04	192	107	5	4989ebb8812b8af1870599acd932849122c05a29
ToppCell	IPF-Epithelial-Ciliated\|World / Disease state, Lineage and Cell class	ERICH3 DNAI2 VWA3B KIAA2012 MAP3K19	1.00e-04	192	107	5	d903bbd6c18e29e2c4cdedeb3fea1fd5ad7baa11
ToppCell	IPF-Epithelial-Ciliated\|IPF / Disease state, Lineage and Cell class	ERICH3 DNAI2 VWA3B KIAA2012 MAP3K19	1.00e-04	192	107	5	354adc1354bf596fbc60dd45c0169688e6f45165
ToppCell	Bronchial_Brush\|World / Tissue, Lineage and Cell class of Lung Cells from 10X	ERICH3 DNAI2 VWA3B KIAA2012 MAP3K19	1.03e-04	193	107	5	3e693ac4c92576e3f2c9efdd3f1d96d3d336e260
ToppCell	Control-Epithelial-Ciliated\|Epithelial / Disease state, Lineage and Cell class	ERICH3 DNAI2 VWA3B KIAA2012 MAP3K19	1.03e-04	193	107	5	0e37d454f3735edd936ee9a5f5f516ac3aad400e
ToppCell	COVID-19-Heart-CM_+_EC_+_Pericyte\|Heart / Disease (COVID-19 only), tissue and cell type	MYOM3 OBSCN SORBS1 GREB1L FHIP1A	1.03e-04	193	107	5	dd5378a1ef8eb0eda9a3aae62f3c2f3a1402bda0
ToppCell	15-Trachea-Epithelial-Multiciliated_cell\|Trachea / Age, Tissue, Lineage and Cell class	MRPS31 ERICH3 DNAI2 VWA3B MAP3K19	1.03e-04	193	107	5	aa3acc7571405169efb656d214f3a8cbf988362e
ToppCell	Bronchial_Biopsy-Epithelial-Ciliated_1\|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X	ERICH3 DNAI2 VWA3B KIAA2012 MAP3K19	1.03e-04	193	107	5	0b62a6ddd7c42efd9f39781971d1438501e1fa8d
ToppCell	Bronchial_Brush-Epithelial-Ciliated_1\|Bronchial_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X	MRPS31 ERICH3 VWA3B KIAA2012 MAP3K19	1.05e-04	194	107	5	b4ce60c06568123008b1081d644733cb91c28f51
ToppCell	Bronchial_Brush-Epithelial-Ciliated_1\|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X	MRPS31 ERICH3 VWA3B KIAA2012 MAP3K19	1.05e-04	194	107	5	7a7ddccfe72a4a0dc4d1a5c809988f0069f9f1a3
ToppCell	wk_15-18-Epithelial-Proximal_epithelial\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	ERICH3 DNAI2 VWA3B KIAA2012 MAP3K19	1.05e-04	194	107	5	b0477583301dc6d9767b667bd2f8f94fbfaa6f81
ToppCell	RA-03._Atrial_Cardiomyocyte\|RA / Chamber and Cluster_Paper	MYOM3 OBSCN SORBS1 GREB1L TBC1D4	1.05e-04	194	107	5	c3535f7cc0076653c72db582047cff053c322397
ToppCell	COVID-19-Epithelial-Ciliated_cells\|COVID-19 / Condition, Lineage and Cell class	ERICH3 DNAI2 VWA3B KIAA2012 MAP3K19	1.05e-04	194	107	5	43be5fbd51dd58839cb03ca3ddd05a458e1ddb74
Drug	Ethamsylate [2624-44-4]; Down 200; 15.2uM; PC3; HT_HG-U133A	GGA2 LAT2 ANKRD26 GCDH SBNO2 RUSC2 GREB1L RIPOR1 CBX8	3.20e-07	198	104	9	4576_DN
Drug	Rilmenidine hemifumarate [54187-04-1]; Down 200; 8.4uM; HL60; HT_HG-U133A	PDK3 ANKRD26 ARMC9 NCAPH2 SBNO2 PPP1R3C PAOX BAZ2A	3.45e-06	197	104	8	3133_DN
Drug	Ticarcillin sodium [4697-14-7]; Up 200; 9.4uM; PC3; HT_HG-U133A	GGA2 LAT2 SORBS1 ZNF688 LLGL1 BAZ2A BUB1 OSMR	3.58e-06	198	104	8	5829_UP
Drug	Tetrandrine [518-34-3]; Down 200; 6.4uM; MCF7; HT_HG-U133A	NCAPH2 SBNO2 PPP1R3C PAOX BAZ2A RIPOR1 TADA2A TGS1	3.58e-06	198	104	8	7178_DN
Drug	(-)-MK 801 hydrogen maleate [77086-19-2]; Down 200; 11.8uM; MCF7; HT_HG-U133A	PDK3 NCAPH2 SBNO2 NRSN2 TBC1D4 BAZ2A RIPOR1 TAF15	3.72e-06	199	104	8	6458_DN
Drug	lindleyin	TGFB1 PREP	2.07e-05	2	104	2	CID000042994
Drug	Nocodazole [31430-18-9]; Up 200; 13.2uM; PC3; HT_HG-U133A	PPP1R13L ZNF688 RUSC2 TBC1D4 BRCA2 BUB1 ABCC2	2.71e-05	190	104	7	7145_UP
Drug	Zaprinast [37762-06-4]; Down 200; 14.8uM; PC3; HT_HG-U133A	GGA2 LAT2 SBNO2 PPP1R3C BRCA2 TAF15 OSMR	2.99e-05	193	104	7	6749_DN
Drug	11-deoxy-16,16-dimethyl Prostaglandin E2; Down 200; 10uM; PC3; HT_HG-U133A	GGA2 LAT2 PAOX BUB1 FUS OSMR CBX8	3.10e-05	194	104	7	7538_DN
Drug	Fludrocortisone acetate [514-36-3]; Down 200; 9.4uM; MCF7; HT_HG-U133A	LAT2 RUSC2 GREB1L BAZ2A DNAI2 POU2F3 CBX8	3.10e-05	194	104	7	3977_DN
Drug	Enalapril maleate [76095-16-4]; Down 200; 8.2uM; PC3; HT_HG-U133A	GCDH TBC1D4 BRCA2 ANAPC2 TMEM132A TAB1 OSMR	3.30e-05	196	104	7	7265_DN
Drug	Nomifensine maleate [32795-47-4]; Down 200; 11.2uM; PC3; HT_HG-U133A	GGA2 NCAPH2 WAC NRSN2 BRCA2 PREP BUB1	3.30e-05	196	104	7	5863_DN
Drug	Alfadolone acetate [23930-37-2]; Down 200; 10.2uM; HL60; HT_HG-U133A	ANKRD26 SBNO2 PAOX PIGT LATS1 BAZ2A ABCC2	3.41e-05	197	104	7	3127_DN
Drug	Alclometasone dipropionate [667634-13-2]; Down 200; 7.6uM; PC3; HT_HG-U133A	PDK3 ANKRD26 ARMC9 NCAPH2 BAZ2A TADA2A TGS1	3.41e-05	197	104	7	5752_DN
Drug	Amidopyrine [58-15-1]; Up 200; 17.2uM; MCF7; HT_HG-U133A	ALLC ANKRD26 SORBS1 TULP2 LATS1 TADA2A HDC	3.41e-05	197	104	7	2222_UP
Drug	Ornidazole [16773-42-5]; Down 200; 18.2uM; PC3; HT_HG-U133A	PDK3 ANKRD26 ARMC9 SBNO2 RUSC2 LATS1 TAF15	3.53e-05	198	104	7	5064_DN
Drug	Piretanide [55837-27-9]; Up 200; 11uM; MCF7; HT_HG-U133A	ANKRD26 SORBS1 DENND1C SBNO2 BAZ2A RIPOR1 MAPK8IP2	3.64e-05	199	104	7	6828_UP
Drug	Moxisylyte hydrochoride [964-52-3]; Down 200; 12.6uM; MCF7; HT_HG-U133A	GGA2 ANKRD26 ZNF688 PPP1R3C NRSN2 ANAPC2 TAF15	3.76e-05	200	104	7	1682_DN
Drug	friedelin	SEPTIN4 CBX8	1.23e-04	4	104	2	CID000091472
Drug	17-AAG; Up 200; 1uM; PC3; HT_HG-U133A	GCDH NCAPH2 RGS2 PPP1R3C BUB1 TAF15	1.96e-04	183	104	6	1206_UP
Drug	[(2S,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-2-[4-(3-oxobutyl)phenoxy]oxan-3-yl] 3,4,5-trihydroxybenzoate	TGFB1 PREP	2.05e-04	5	104	2	CID010390322
Drug	Triamcinolone [124-94-7]; Up 200; 10.2uM; HL60; HG-U133A	GGA2 CAMK2A SCYL3 BAZ2A PREP RCOR3	2.27e-04	188	104	6	1395_UP
Drug	Doxycycline hydrochloride [10592-13-9]; Up 200; 8.4uM; MCF7; HT_HG-U133A	GGA2 NCAPH2 RUSC2 NRSN2 OSMR CBX8	2.47e-04	191	104	6	7195_UP
Drug	Ceforanide [60925-61-3]; Down 200; 7.6uM; MCF7; HT_HG-U133A	PDK3 SCYL3 GCDH SBNO2 TADA2A TGS1	2.47e-04	191	104	6	5351_DN
Drug	17-AAG; Up 200; 1uM; MCF7; HT_HG-U133A	CLSTN3 GGA2 LAT2 SORBS1 NCAPH2 RGS2	2.62e-04	193	104	6	5914_UP
Drug	Hydrastinine hydrochloride [4884-68-8]; Up 200; 16.4uM; MCF7; HT_HG-U133A	CLSTN3 LAT2 RGS2 RUSC2 MYO3A BUB1	2.62e-04	193	104	6	2283_UP
Drug	Phenylpropanolamine hydrochloride [154-41-6]; Down 200; 21.4uM; PC3; HT_HG-U133A	PDK3 SORBS1 NCAPH2 ZNF688 RUSC2 TAF15	2.62e-04	193	104	6	6699_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; HL60; HT_HG-U133A	GGA2 LAT2 PDK3 RUSC2 PPP1R3C TAB1	2.62e-04	193	104	6	2949_DN
Drug	Pimethixene maleate [13187-06-9]; Down 200; 9.8uM; MCF7; HT_HG-U133A	SBNO2 BRCA2 BAZ2A TAB1 OBI1 CBX8	2.69e-04	194	104	6	7468_DN
Drug	Etodolac [41340-25-4]; Down 200; 14uM; PC3; HT_HG-U133A	GGA2 NCAPH2 FOXJ3 RUSC2 PPP1R3C OSMR	2.69e-04	194	104	6	2091_DN
Drug	(-) -Levobunolol hydrochloride [27912-14-7]; Down 200; 12.2uM; MCF7; HT_HG-U133A	NCAPH2 GREB1L PAOX LLGL1 TAF15 TAB1	2.69e-04	194	104	6	3354_DN
Drug	Griseofulvin [126-07-8]; Down 200; 11.2uM; MCF7; HT_HG-U133A	ANKRD26 NRSN2 BAZ2A BUB1 TAF15 FUS	2.69e-04	194	104	6	2293_DN
Drug	Capsaicin [404-86-4]; Down 200; 13uM; PC3; HT_HG-U133A	NCAPH2 RUSC2 BRCA2 BUB1 TAF15 FUS	2.69e-04	194	104	6	4612_DN
Drug	PF-00562151-00 [351320-12-2]; Up 200; 10uM; MCF7; HT_HG-U133A	LAT2 NCAPH2 RUSC2 GREB1L PAOX BAZ2A	2.69e-04	194	104	6	5954_UP
Drug	F0447-0125; Down 200; 10uM; MCF7; HT_HG-U133A	ANKRD26 PPP1R3C BUB1 TAF15 TAB1 POU2F3	2.76e-04	195	104	6	6424_DN
Drug	Rapamycin; Down 200; 0.1uM; HL60; HT_HG-U133A	ARMC9 RUSC2 PPP1R3C BAZ2A DNAI2 TAB1	2.76e-04	195	104	6	6180_DN
Drug	Dapsone [80-08-0]; Down 200; 16.2uM; PC3; HT_HG-U133A	GGA2 PDK3 SBNO2 RUSC2 BRCA2 TMEM132A	2.76e-04	195	104	6	1827_DN
Drug	Tranexamic acid [1197-18-8]; Down 200; 25.4uM; HL60; HG-U133A	GGA2 HECW1 GCDH NCAPH2 PPP1R13L APOBR	2.76e-04	195	104	6	1401_DN
Drug	Probucol [23288-49-5]; Up 200; 7.8uM; MCF7; HT_HG-U133A	LAT2 NCAPH2 DENND1C RGS2 BAZ2A ABCC2	2.76e-04	195	104	6	5261_UP
Drug	Minocycline hydrochloride [13614-98-7]; Down 200; 8uM; PC3; HT_HG-U133A	GGA2 NCAPH2 SBNO2 TBC1D4 TMEM132A OSMR	2.76e-04	195	104	6	5077_DN
Drug	Naringenine [480-41-1]; Down 200; 14.6uM; PC3; HT_HG-U133A	ANKRD26 RUSC2 BUB1 RIPOR1 MAPK8IP2 TGS1	2.76e-04	195	104	6	4597_DN
Drug	Cefamandole sodium salt [30034-03-8]; Up 200; 8.2uM; PC3; HT_HG-U133A	CAMK2A NCAPH2 GREB1L BAZ2A TAB1 TGS1	2.76e-04	195	104	6	7394_UP
Drug	Betonicine [515-25-3]; Up 200; 25.2uM; MCF7; HT_HG-U133A	HECW1 LAT2 GREB1L PAOX BUB1 HDC	2.76e-04	195	104	6	3642_UP
Drug	Dicumarol [66-76-2]; Down 200; 11.8uM; MCF7; HT_HG-U133A	LAT2 NCAPH2 SBNO2 GREB1L PAOX ABCC2	2.76e-04	195	104	6	3941_DN
Drug	Chlorambucil [305-03-3]; Down 200; 13.2uM; MCF7; HT_HG-U133A	GGA2 NCAPH2 GREB1L BAZ2A BUB1 OSMR	2.76e-04	195	104	6	4345_DN
Drug	Mebeverine hydrochloride [2753-45-9]; Down 200; 8.6uM; MCF7; HT_HG-U133A	GCDH NCAPH2 RGS2 TADA2A FUS CBX8	2.76e-04	195	104	6	6795_DN
Drug	Cetirizine dihydrochloride [83881-52-1]; Down 200; 8.6uM; HL60; HT_HG-U133A	GGA2 LAT2 FOXJ3 PPP1R3C BAZ2A TGS1	2.76e-04	195	104	6	2468_DN
Drug	radicicol, diheterospora chlamydosporia; Down 200; 0.1uM; MCF7; HT_HG-U133A	ARMC9 NCAPH2 PAOX NRSN2 TADA2A FUS	2.76e-04	195	104	6	5579_DN
Drug	Spaglumic acid [4910-46-7]; Down 200; 13.2uM; HL60; HT_HG-U133A	PDK3 RUSC2 ANAPC2 RIPOR1 TAB1 TGS1	2.76e-04	195	104	6	2962_DN
Drug	Triamterene [396-01-0]; Up 200; 15.8uM; MCF7; HT_HG-U133A	GGA2 NCAPH2 DNAI2 TADA2A OSMR MAPK8IP2	2.84e-04	196	104	6	1697_UP
Drug	Diphemanil methylsulfate [62-97-5]; Up 200; 10.2uM; MCF7; HT_HG-U133A	CLSTN3 SEPTIN4 NCAPH2 GREB1L NRSN2 DNAI2	2.84e-04	196	104	6	1494_UP
Drug	GSK-3 Inhibitor IX; Down 200; 0.5uM; PC3; HT_HG-U133A	GGA2 LAT2 PDK3 NCAPH2 SBNO2 FUS	2.84e-04	196	104	6	6585_DN
Drug	Mafenide hydrochloride [138-37-4]; Down 200; 18uM; MCF7; HT_HG-U133A	SBNO2 TGFB1 PAOX PREP BUB1 FUS	2.84e-04	196	104	6	5499_DN
Drug	Diphenidol hydrochloride [3254-89-5]; Down 200; 11.6uM; HL60; HT_HG-U133A	GGA2 NCAPH2 WAC PAOX TADA2A FUS	2.84e-04	196	104	6	2374_DN
Drug	Scoulerine [6451-73-6]; Up 200; 12.2uM; MCF7; HT_HG-U133A	HECW1 SBNO2 NRSN2 LATS1 BAZ2A OSMR	2.84e-04	196	104	6	5536_UP
Drug	Baclofen (R,S) [1134-47-0]; Up 200; 18.8uM; PC3; HG-U133A	GGA2 LAT2 SCYL3 SBNO2 LLGL1 PREP	2.84e-04	196	104	6	1952_UP
Drug	Nalidixic acid sodium salt hydrate; Down 200; 14.6uM; PC3; HT_HG-U133A	GGA2 NCAPH2 SBNO2 BAZ2A TMEM132A OSMR	2.84e-04	196	104	6	7367_DN
Drug	Thiethylperazine malate [52239-63-1]; Up 200; 6uM; MCF7; HT_HG-U133A	HECW1 SBNO2 PAOX BRCA2 OSMR ABCC2	2.84e-04	196	104	6	6232_UP
Drug	Isosorbide dinitrate [87-33-2]; Down 200; 17uM; PC3; HT_HG-U133A	ZNF688 RUSC2 BAZ2A BUB1 ABCC2 MAPK8IP2	2.84e-04	196	104	6	3720_DN
Drug	Famotidine [76824-35-6]; Down 200; 11.8uM; MCF7; HT_HG-U133A	GGA2 NCAPH2 RGS2 TMEM132A TAF15 TGS1	2.84e-04	196	104	6	5011_DN
Drug	Miconazole [22916-47-8]; Up 200; 9.6uM; PC3; HT_HG-U133A	CLSTN3 NCAPH2 DENND1C ZNF688 LLGL1 POU2F3	2.84e-04	196	104	6	6615_UP
Drug	Canavanine sulfate monohydrate (L,+) [206996-57-8]; Down 200; 13.6uM; HL60; HT_HG-U133A	ZNF688 PPP1R3C PAOX BAZ2A TAF15 TAB1	2.92e-04	197	104	6	2141_DN
Drug	Cefixime [79350-37-1]; Up 200; 8.8uM; HL60; HT_HG-U133A	GGA2 ANKRD26 NCAPH2 TBC1D4 TAF15 TAB1	2.92e-04	197	104	6	1310_UP
Drug	S-(+)-ibuprofen [51146-56-6]; Up 200; 19.4uM; MCF7; HT_HG-U133A	GGA2 SORBS1 LLGL1 BAZ2A TADA2A OSMR	2.92e-04	197	104	6	6471_UP
Drug	Allantoin [97-59-6]; Down 200; 25.2uM; HL60; HT_HG-U133A	GCDH NCAPH2 PIGT BRCA2 TAF15 TGS1	2.92e-04	197	104	6	1842_DN
Drug	Benfotiamine [22457-89-2]; Down 200; 8.6uM; MCF7; HT_HG-U133A	LAT2 NCAPH2 PAOX TADA2A POU2F3 MAPK8IP2	2.92e-04	197	104	6	3837_DN
Drug	Terconazole [67915-31-5]; Down 200; 7.6uM; PC3; HT_HG-U133A	SBNO2 PPP1R3C BRCA2 TAF15 MAPK8IP2 TGS1	2.92e-04	197	104	6	4583_DN
Drug	Tiaprofenic acid [33005-95-7]; Down 200; 15.4uM; PC3; HT_HG-U133A	GGA2 LAT2 RUSC2 RIPOR1 TAB1 TADA2A	2.92e-04	197	104	6	4091_DN
Drug	aspirin, USP; Up 200; 100uM; MCF7; HT_HG-U133A	ANKRD26 NCAPH2 DENND1C PAOX LLGL1 MAPK8IP2	2.92e-04	197	104	6	6924_UP
Drug	SR-95639A [115767-94-7]; Down 200; 10uM; MCF7; HT_HG-U133A	NCAPH2 BAZ2A RIPOR1 TAF15 TAB1 OSMR	2.92e-04	197	104	6	4977_DN
Drug	Ketotifen fumarate [34580-14-8]; Up 200; 9.4uM; MCF7; HT_HG-U133A	GGA2 HECW1 PAOX OSMR OBI1 CBX8	2.92e-04	197	104	6	7199_UP
Drug	Reserpinic acid hydrochloride; Down 200; 9.2uM; HL60; HT_HG-U133A	ANKRD26 ARMC9 NCAPH2 SBNO2 BUB1 TAB1	2.92e-04	197	104	6	2903_DN
Drug	(-)-quinpirole hydrochloride; Up 200; 1uM; MCF7; HG-U133A	ALLC GGA2 PDK3 BAZ2A PREP CBX8	2.92e-04	197	104	6	456_UP
Drug	Clorgyline hydrochloride [17780-75-5]; Down 200; 13uM; HL60; HG-U133A	GGA2 HECW1 LAT2 GCDH DENND1C TBC1D4	2.92e-04	197	104	6	1604_DN
Drug	Deltaline [6836-11-9]; Down 200; 7.8uM; MCF7; HT_HG-U133A	LAT2 ANKRD26 GCDH TGFB1 PAOX TBC1D4	2.92e-04	197	104	6	3831_DN
Drug	Bepridil hydrochloride [74764-40-2]; Down 200; 10uM; PC3; HT_HG-U133A	NCAPH2 BAZ2A BUB1 TAF15 FUS TGS1	2.92e-04	197	104	6	4613_DN
Drug	Mebendazole [31431-39-7]; Down 200; 13.6uM; MCF7; HT_HG-U133A	ANKRD26 NCAPH2 PPP1R3C PAOX RCOR3 RIPOR1	2.92e-04	197	104	6	2300_DN
Drug	Cefepime hydrochloride [123171-59-5]; Up 200; 7.4uM; PC3; HT_HG-U133A	GGA2 SEPTIN4 LAT2 PDK3 GREB1L BUB1	2.92e-04	197	104	6	5761_UP
Drug	Succinylsulfathiazole [116-43-8]; Down 200; 11.2uM; PC3; HT_HG-U133A	GGA2 NCAPH2 FOXJ3 LATS1 TMEM132A TAF15	2.92e-04	197	104	6	4265_DN
Drug	Harmaline hydrochloride dihydrate [6027-98-1]; Up 200; 14uM; MCF7; HT_HG-U133A	LAT2 RUSC2 TBC1D4 DNAI2 TADA2A ABCC2	2.92e-04	197	104	6	4968_UP
Drug	Orlistat; Down 200; 10uM; PC3; HT_HG-U133A	CLSTN3 TBC1D4 BUB1 TAF15 OSMR CBX8	3.00e-04	198	104	6	6388_DN
Drug	Deptropine citrate [2169-75-7]; Down 200; 7.6uM; MCF7; HT_HG-U133A	MRPS31 PDK3 GCDH PAOX TMEM132A OBI1	3.00e-04	198	104	6	5543_DN
Drug	Lymecycline [992-21-2]; Up 200; 6.6uM; PC3; HT_HG-U133A	ARMC9 NCAPH2 ZNF688 PPP1R3C ABCC2 TGS1	3.00e-04	198	104	6	7291_UP
Drug	Meprylcaine hydrochloride [956-03-6]; Up 200; 14.8uM; PC3; HT_HG-U133A	CLSTN3 HECW1 GREB1L BUB1 CBX8 MAP3K19	3.00e-04	198	104	6	5723_UP
Drug	Phenethicillin potassium salt [132-93-4]; Up 200; 10uM; MCF7; HT_HG-U133A	NCAPH2 PAOX BAZ2A BUB1 DNAI2 OSMR	3.00e-04	198	104	6	6239_UP
Drug	ICI 182,780; Up 200; 1uM; MCF7; HT_HG-U133A	ANKRD26 NCAPH2 FOXJ3 RGS2 PPP1R3C MAPK8IP2	3.00e-04	198	104	6	6925_UP
Drug	Cefaclor [70356-03-5]; Down 200; 10.4uM; MCF7; HT_HG-U133A	ARMC9 TBC1D4 RIPOR1 TAF15 TADA2A MAPK8IP2	3.00e-04	198	104	6	4967_DN
Drug	Pentetic acid [67-43-6]; Down 200; 10.2uM; PC3; HT_HG-U133A	SORBS1 NCAPH2 GREB1L PPP1R3C BRCA2 TGS1	3.00e-04	198	104	6	4669_DN
Drug	Levopropoxyphene napsylate [5714-90-9]; Down 200; 7.4uM; PC3; HT_HG-U133A	GGA2 PDK3 NCAPH2 RUSC2 BAZ2A CBX8	3.00e-04	198	104	6	5083_DN
Drug	Furaltadone hydrochloride [3759-92-0]; Down 200; 11uM; PC3; HT_HG-U133A	LAT2 ANKRD26 BAZ2A ANAPC2 TAF15 OSMR	3.00e-04	198	104	6	3756_DN
Drug	Meticrane [1084-65-7]; Up 200; 14.6uM; MCF7; HT_HG-U133A	NCAPH2 RUSC2 GREB1L BAZ2A TADA2A CBX8	3.00e-04	198	104	6	1671_UP
Drug	Ethaverine hydrochloride [985-13-7]; Up 200; 9.2uM; MCF7; HT_HG-U133A	ANKRD26 SBNO2 BAZ2A DNAI2 RIPOR1 OSMR	3.08e-04	199	104	6	5337_UP
Drug	Methiothepin maleate [19728-88-2]; Up 200; 8.4uM; PC3; HT_HG-U133A	NCAPH2 RUSC2 PAOX NRSN2 BAZ2A TGS1	3.08e-04	199	104	6	6312_UP
Drug	Arecoline hydrobromide [300-08-3]; Down 200; 17uM; MCF7; HT_HG-U133A	GGA2 SBNO2 PAOX DNAI2 TADA2A OSMR	3.08e-04	199	104	6	5423_DN
Drug	Desipramine hydrochloride [58-28-6]; Down 200; 13.2uM; PC3; HT_HG-U133A	NCAPH2 ZNF688 BRCA2 TMEM132A TAF15 CBX8	3.08e-04	199	104	6	6693_DN
Drug	Prilocaine hydrochloride [1786-81-8]; Up 200; 15.6uM; PC3; HT_HG-U133A	CAMK2A NCAPH2 DENND1C APOBR TULP2 BUB1	3.08e-04	199	104	6	4284_UP
Drug	Neomycin sulfate [1405-10-3]; Up 200; 4.2uM; HL60; HG-U133A	GGA2 PDK3 BAZ2A ANAPC2 TADA2A METTL22	3.08e-04	199	104	6	1383_UP
Drug	Triflupromazine hydrochloride [1098-60-8]; Down 200; 10.2uM; PC3; HT_HG-U133A	GGA2 PDK3 GCDH BRCA2 TAF15 METTL22	3.08e-04	199	104	6	1813_DN
Drug	Gentamicine sulfate [1405-41-0]; Down 200; 2.6uM; PC3; HT_HG-U133A	ZNF688 NRSN2 BAZ2A ANAPC2 TMEM132A TGS1	3.17e-04	200	104	6	5883_DN
Drug	Condelphine [7633-69-4]; Up 200; 8.8uM; MCF7; HT_HG-U133A	GGA2 NRSN2 LLGL1 BUB1 ABCC2 CBX8	3.17e-04	200	104	6	3538_UP
Disease	kidney cancer (implicated_via_orthology)	LATS1 LLGL1 LATS2	6.68e-06	11	103	3	DOID:263 (implicated_via_orthology)
Disease	amyotrophic lateral sclerosis type 6 (implicated_via_orthology)	TAF15 FUS	3.61e-05	3	103	2	DOID:0060198 (implicated_via_orthology)
Disease	Colorectal Carcinoma	CLSTN3 OBSCN DSCAML1 WAC TGFB1 FAT1 BUB1 ABCC2 MTDH HDC	1.76e-04	702	103	10	C0009402
Disease	cortisol secretion measurement	ALLC MYO3A	2.51e-04	7	103	2	EFO_0004642
Disease	benign neoplasm (implicated_via_orthology)	LATS1 LATS2	3.33e-04	8	103	2	DOID:0060072 (implicated_via_orthology)
Disease	aplastic anemia (is_marker_for)	TGFB1 ANAPC2	4.28e-04	9	103	2	DOID:12449 (is_marker_for)
Disease	frontotemporal dementia (implicated_via_orthology)	TAF15 FUS	7.78e-04	12	103	2	DOID:9255 (implicated_via_orthology)
Disease	hematocrit	GCDH SORBS1 FAT1 MIDN TBC1D4 LLGL1 TADA2A OSMR ARHGAP21 UBE2Q2 MAP3K19	8.16e-04	1011	103	11	EFO_0004348
Disease	Hepatomegaly	CAMK2A TGFB1 HDC	9.00e-04	54	103	3	C0019209
Disease	carcinoma (implicated_via_orthology)	LATS1 LLGL1 LATS2	1.47e-03	64	103	3	DOID:305 (implicated_via_orthology)
Disease	adiponectin measurement	ZC3H11B LLGL1 VWA3B GRHL3	1.74e-03	146	103	4	EFO_0004502
Disease	esophagus squamous cell carcinoma (is_marker_for)	FAT1 SETD5 CBX8	2.24e-03	74	103	3	DOID:3748 (is_marker_for)
Disease	osteoarthritis, hip, osteoarthritis, knee, total joint arthroplasty	ZC3H11B TGFB1	2.43e-03	21	103	2	EFO_0004616, EFO_0010726, EFO_1000786
Disease	cancer (implicated_via_orthology)	LATS1 LLGL1 LATS2 BRCA2 CBX8	2.53e-03	268	103	5	DOID:162 (implicated_via_orthology)
Disease	arginine measurement	GCDH DNAI2	2.91e-03	23	103	2	EFO_0020990
Disease	Colorectal Neoplasms	TGFB1 FAT1 BUB1 ABCC2 MTDH	2.91e-03	277	103	5	C0009404
Disease	alkaline phosphatase measurement	ELP5 TULP2 SBNO2 WAC MYO3A LLGL1 RNF103 UNC13C TAB1 ARHGAP21	2.92e-03	1015	103	10	EFO_0004533
Disease	Hepatolenticular Degeneration	CAMK2A SDHAF2	3.17e-03	24	103	2	C0019202
Disease	Hepatic Form of Wilson Disease	CAMK2A SDHAF2	3.17e-03	24	103	2	C1527352
Disease	Cerebral Astrocytoma	LATS1 LATS2	3.44e-03	25	103	2	C0750935
Disease	Intracranial Astrocytoma	LATS1 LATS2	3.44e-03	25	103	2	C0750936
Disease	Astrocytoma	LATS1 LATS2	3.44e-03	25	103	2	C0004114
Disease	Grade I Astrocytoma	LATS1 LATS2	3.44e-03	25	103	2	C1704230
Disease	Subependymal Giant Cell Astrocytoma	LATS1 LATS2	3.44e-03	25	103	2	C0205768
Disease	Mixed oligoastrocytoma	LATS1 LATS2	3.44e-03	25	103	2	C0547065
Disease	Pilocytic Astrocytoma	LATS1 LATS2	3.44e-03	25	103	2	C0334583
Disease	Juvenile Pilocytic Astrocytoma	LATS1 LATS2	3.44e-03	25	103	2	C0280783
Disease	Diffuse Astrocytoma	LATS1 LATS2	3.44e-03	25	103	2	C0280785
Disease	Childhood Cerebral Astrocytoma	LATS1 LATS2	3.44e-03	25	103	2	C0338070

Protein segments in the cluster

Peptide	Gene	Start	Entry
AWKPTAEQPELAEEF	ERICH3	811	Q5RHP9
LSSEFWPPFKDEKLE	ANAPC2	596	Q9UJX6
ASSDPKDPDLFWDDS	CLSTN3	886	Q9BQT9
QAPTLPDISDDKDEW	BUB1	476	O43683
DWTATDPKEPADLVA	ALLC	186	Q8N6M5
DEAESSPDPQALWFN	BAZ2A	1311	Q9UIF9
EDPAERPVNSWASDF	AP4B1	546	Q9Y6B7
KPGVDDSWPTSDDED	ANKRD26	251	Q9UPS8
IESPWDSESISENFP	ANKRD26	416	Q9UPS8
SDSYIWDLENPNKPE	DNAI2	196	Q9GZS0
FDIAWTSQPLDPSSD	DENND1C	726	Q8IV53
AADFLPKWLDPENST	ECD	121	O95905
SLADLANFTPFPDEW	RCOR2	121	Q8IZ40
ANFTPFPDEWTVEDK	RCOR2	126	Q8IZ40
NFTPFPDEWTVEDKV	RCOR3	81	Q9P2K3
DDPPSAKAAIDWFDG	TAF15	291	Q92804
SLVDDAKFPEPNFWS	OSMR	116	Q99650
ADSLAQAAEDDWPPF	LLGL1	486	Q15334
SAPEDPDSWDSIFGD	HDC	46	P19113
SPSDSDSIQKPSWDF	FAT1	4316	Q14517
TSNFDPVDPDKLWSD	LATS1	1036	O95835
NFDPVDEESPWNDAS	LATS2	1001	Q9NRM7
QEDDGQDSSPKWPDS	RPS6KC1	486	Q96S38
FDDPPSAKAAIDWFD	FUS	341	P35637
RSEAPESSESWKPEQ	HECW1	381	Q76N89
PSFKELFQDSWTPEL	ARMC9	161	Q7Z3E5
LIQDWSSDSPPDIFS	KIAA1109	501	Q2LD37
EPFPAFKSWQEDSES	FAM13B	481	Q9NYF5
ESEPDLSEDADSPWL	MAPK8IP2	336	Q13387
ESSLEDPSRYKPQWE	C9orf131	401	Q5VYM1
EWKPTSFFLLSPSDQ	OBI1	606	Q5W0B1
EDPWLSPKYDAQESQ	KIAA2012	926	Q0VF49
PSPWPKSSIFDADEE	GGA2	176	Q9UJY4
WNSSFLDSPEADLPL	ABCC2	11	Q92887
WLSQDTKAEPLDPEA	NRSN2	141	Q9GZP1
SQSEGEPWPDIESFS	GREB1L	1366	Q9C091
KWLNDAESSPSDPSV	POU2F3	251	Q9UKI9
WDESLSLSDSDFDKP	PABIR2	86	Q7Z309
VPQPSTEAAWFKEET	OBSCN	356	Q5VST9
SENFPSSSKKSEEWP	SCYL3	516	Q8IZE3
DPYAWLEDPDSEQTK	PREP	26	P48147
NERPEFQKDPTWSET	PAN3	791	Q58A45
WDPEAFQLAESQPKE	DNAH1	4176	Q9P2D7
EWNRDNSDPFHSEPK	FHIP1A	696	Q05DH4
RWQPDSTFKDDPQES	GRHL3	191	Q8TE85
PEEESWSPSLTNLEK	CBX8	346	Q9HC52
PISLNWFEELSSEAP	BRCA2	26	P51587
AKSSRPEFDWQDPLV	GCDH	41	Q92947
DPAPAVKWTKDSEDS	DSCAML1	1316	Q8TD84
SLPPDDIQDDFDWDS	FOXJ3	606	Q9UPW0
SSADPNSDWNAPAEE	MTDH	386	Q86UE4
PWASSPEDFLQKSKD	NSMAF	481	Q92636
FRDPLNWSKTEEAFP	ELP5	86	Q8TE02
DSITWKPYDAADLDP	F10	196	P00742
FPVESDWDEDPDLFL	RNF103	476	O00237
PPKAWNESDLDVAYE	PPP1R13L	246	Q8WUF5
PSEDSWAVPSEKNSN	MAP3K19	851	Q56UN5
TSPLEDAAPELQDAW	PAOX	346	Q6QHF9
WATEAKPAPEIFENE	SDHAF2	121	Q9NX18
LDFEDSVWKPEVNPD	MIDN	446	Q504T8
WGRFSKPPEDDDANS	LAT2	121	Q9GZY6
QFPTEDWSAQPATED	RPSA	261	P08865
DQEWKLSSDESPRNP	RUSC2	226	Q8N2Y8
KEAPETDTSPSLWDV	MRPS31	266	Q92665
EIPFDSWNFENPTDE	SYTL5	511	Q8TDW5
KPSPEEAQLWSEAFD	RGS2	71	P41220
QKDSSEATGWEEPSP	TNRC6C	701	Q9HCJ0
FSDLPEEPAWDLQFD	PPP1R3C	101	Q9UQK1
RSPWGKLDPYDSSED	SEPTIN4	106	O43236
PDSSPLELSEFLWVD	TMEM132A	336	Q24JP5
SDNGDEKAEPSPQSW	SYNE2	4126	Q8WXH0
SHPPEDSWLKFRSEN	TAB1	46	Q15750
SDFPVLDPSWTAQEE	TADA2A	66	O75478
EPSPTWESNITEKDS	SETD5	1196	Q9C0A6
WDDNPAPSTHDKLFQ	SBNO2	136	Q9Y2G9
WAQDGSEDEPPKDSD	SAMD11	456	Q96NU1
PSKTSDAPYDSADDW	WAC	121	Q9BTA9
YWPNTEELKPSDAET	STARD9	1376	Q9P2P6
PPNDHSQDSEWSKRE	STARD9	4181	Q9P2P6
DPKVPFSWSQEEISD	METTL22	276	Q9BUU2
DFPSPEWDTVTPEAK	CAMK2A	231	Q9UQM7
SSPLFPEASSEWENQ	PROB1	426	E7EW31
KTTPEADDWSNPSSE	PDK3	381	Q15120
SVKPEASEAFPGAWE	APOBR	611	Q0VD83
KETPDPWQSLDPFDS	NCAPH2	311	Q6IBW4
PIKSWFSDPSDTALL	CTDNEP1	201	O95476
WPESSEKIEDIFSQP	NLRP9	206	Q7RTR0
ASPSPGEETFEDWLE	PNMA5	166	Q96PV4
VEWLNFDPSPDDSTG	PWP1	191	Q13610
FWREAAEPLSEPKED	RNF213	1236	Q63HN8
SSPIWFVDSEDPNLT	UBE2Q2	66	Q8WVN8
PFLSWLPDNSDAELE	TULP2	126	O00295
LQSDDSEDAPPKSWH	UNC13C	766	Q8NB66
AKPVDWEESPLFNSL	PIGT	481	Q969N2
WEESPLFNSLFPVSD	PIGT	486	Q969N2
DIPDSSLWENPDSAQ	REV1	481	Q9UBZ9
LLAPSDSPEWLSFDV	TGFB1	186	P01137
SLKSSSERNDWEPPD	SORBS1	506	Q9BX66
SAWQTFPEEDSDSPQ	TBC1D4	621	O60343
KENRSWESSPFSSPE	MTFR2	331	Q6P444
PPLSVEDDFEKLTWE	ZC3H11B	766	A0A1B0GTU1
ESEAWSPAAQDPEKG	ZNF688	81	P0C7X2
FWPLKEADTQDSREP	VWA3B	1186	Q502W6
EEPWVQVSPEFKDSA	ZNF75A	51	Q96N20
QALSSEPWNFPDTKE	TGS1	221	Q96RS0
FPTIPKNSESAVEWE	TMEM242	121	Q9NWH2
SLSEDETFSWPGPKT	ARHGAP21	36	Q5T5U3
LEVTWSPFDKDDQPS	RIPOR1	316	Q6ZS17
SNTIEPFWDLSLEFP	USP44	486	Q9H0E7
TKSPFWASEPSDQLE	TARM1	201	B6A8C7
SNPPWASTLFEIDEF	LEUTX	151	A8MZ59
FDNFPDPSDTWEITE	MYO3A	11	Q8NEV4
APEAPDSSEFQWSKD	MYOM3	921	Q5VTT5